Cite

HARVARD Citation

    Fujii, H. et al. (2022). Real‐world long‐term analysis of daclatasvir plus asunaprevir in patients with hepatitis C virus infection. JGH open. 6 (5), pp. 344-352. [Online]. 
  
Back to record